INVA8003
Pre-clinical- Indications
- Not specified
Company intelligence / Profile preview
InveniAI
Guilford, Connecticut, United Statesinveniai.com ↗
- Ownership
- Private
- Employees
- ~34
- Development stage
- Phase 3
01
Overview
InveniAI leverages proprietary AI/ML platforms—primarily AlphaMeld®—to identify actionable concepts for the discovery and development of novel therapeutics addressing unmet medical needs. The company’s technology has powered over 150 biopharma collaborations. Its internal pipeline focuses on chronic inflammatory GI diseases via modulation of the gut-brain axis but does not publicly disclose late-stage clinical results. Most value delivered to date appears through external partnerships rather than direct product candidates.
- Therapeutic areas
- GastroenterologyImmunology
- Modalities
- Small moleculeBiologicPeptidesAI-driven drug design
- Industry
- Drug Discovery Services
02
Drug pipeline
1 asset03
Partnerships
Kyowa Kirin Co., Ltd. – multi-year strategic collaboration across multiple therapeutic areas including nephrology, oncology, immunology/allergy & neurology.Numerous unnamed Big Pharma/Specialty Pharma/Biotech partners (>150 collaborations claimed).
Beyond the preview
Go deeper on InveniAI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InveniAI.